Peripheral Vascular Devices Industry Overview

The global peripheral vascular devices market is forecasted to witness robust growth over the forecast period, driven by increasing prevalence of peripheral vascular diseases such as peripheral arterial disease and diabetic foot ulcers. Increasing geriatric population, rising prevalence of diabetes and hypertension, and growing demand for minimally invasive procedures are some of the key factors driving market growth.

Market Outlook

According to the new market research report "Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD  13.4 billion by 2026 from USD  10.3 billion in 2021, at a CAGR of 5.3%  from 2021 to 2026.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

 

Key Market Players

The major players in the peripheral vascular devices market Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).

Regional Analysis

North America dominates the global peripheral vascular devices market.

The peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America accounted for the largest share of the market. The large share of North America can be attributed to the growth in the geriatric population and the high prevalence of peripheral vascular diseases. Furthermore, the presence of key market players in this region ensures high access to medical devices

The global peripheral vascular devices market is expected to witness significant growth over the forecast period, driven by growing prevalence of peripheral vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. Key players in the market are focusing on developing innovative products, launching new products, and expanding their product portfolios in order to gain a competitive advantage in the market.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=790

 

Recent Developments:

·         Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions

·         Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.

Frequently Asked Questions (FAQ):

1.       What is the projected market value of the global peripheral vascular devices market?

2.       What is the estimated growth rate (CAGR) of the global peripheral vascular devices market for the next five years?

3.       Who are the major players offering peripheral vascular devices in the market?

To speak to our analyst for a discussion on the above findings @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=790

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/interventional-cardiology-peripheral-vascular-devices-market.asp